Liability concerns cited by education administrators and nurses regarding the use of stock albuterol in school are overblown, according to researchers who examined how legislation about the issue has played out in Illinois.
A new study shows that even in states with strong stock inhaler/albuterol laws, school administrators and prescribing clinicians fear liability in prescribing and administering the inhalers. The findings were presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Louisville, Kentucky.
Stock inhaler laws, which exist in 18 states, are meant to address the issue of children who come to school without their asthma inhalers, do not possesses inhalers, or do not know they have asthma. Asthma is one of the most common pediatric respiratory conditions and disproportionately affects Black and Latinx children. Stock albuterol can be used by any child experiencing respiratory distress in school.
The study presented at the ACAAI meeting looked at schools in Illinois, which has had a stock albuterol law in place since 2019. The researchers conducted 20 key stakeholder interviews with nurses, clinicians, and school administrators and found that 35% of those interviewed cited difficulty obtaining prescriptions for stock inhalers as a barrier to implementation.
Liability concerns were one reason for the inability to procure prescriptions.
However, a recent systematic review of liability verbiage of stock inhaler laws show that Illinois’ wording is strong, making liability extremely unlikely, the authors said. The law reads that schools, districts, employees, agents, and prescribers “are to incur no liability or professional discipline, except for willful and wanton conduct, as a result of any injury arising from the use of…undesignated asthma medication.”
The study also looked at factors that would make stock inhaler laws easier to implement. The factors include finding a provider to write a prescription, local "champions" to push for implementation, and funding from the state or school district having funding.
“Having an asthma reliever inhaler, such as albuterol, available to any child who might be experiencing respiratory distress is vital to addressing asthma symptoms and/or emergencies that may happen during the school day,” allergist Andrea A. Pappalardo, MD, ACAAI member and lead author of the study, said in a statement. "We wanted to examine the barriers and facilitators to stock inhaler programs in schools in Illinois and throughout states with similar legislation to better understand how we can improve medication access throughout our state, and nationwide.”
“Even though Illinois has strong wording to protect prescribers of stock inhalers and those who administer stock inhalers, prescribers are still cautious of providing a prescription for stock inhalers and related supplies to school districts. Without a prescription, stock inhalers cannot be implemented in schools. Enhanced education and the verbiage related to liability will alleviate these concerns and improve uptake of stock inhalers in Illinois, and other states,” she said.
“Stock inhaler programs provide critical reliever inhaler access in schools where children spend most of their day. Children and staff can benefit from having a stock inhaler available when an inhaler is not present at the school for that individual due to lack of diagnosis, forgetting it at home, or inability to obtain an inhaler for a multitude of access-related issues. Having potentially life-saving medications for asthma emergencies and daily symptoms alike is critical to keeping our children in class where they belong.”
Reference
Pappalardo AA, Wrona J, Hardy P, Schwartz A, Cambell A. Liability: a misunderstood barrier to stock albuterol implementation in Illinois schools. Presented at: ACAAI 2022 Annual Scientific Meeting; November 10-14, 2022; Louisville, KY. Abstract P094.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More